Nasr R - Search Results

1

RXR is an essential component of the oncogenic PML/RARA complex in vivo.

Zhu J, Nasr R, Pérès L, Riaucoux-Lormière F, Honoré N, Berthier C, Kamashev D, Zhou J, Vitoux D, Lavau C, de Thé H. Zhu J, et al. Among authors: nasr r. Cancer Cell. 2007 Jul;12(1):23-35. doi: 10.1016/j.ccr.2007.06.004. Cancer Cell. 2007. PMID: 17613434 Free article.

2

Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway.

Lallemand-Breitenbach V, Jeanne M, Benhenda S, Nasr R, Lei M, Peres L, Zhou J, Zhu J, Raught B, de Thé H. Lallemand-Breitenbach V, et al. Among authors: nasr r. Nat Cell Biol. 2008 May;10(5):547-55. doi: 10.1038/ncb1717. Epub 2008 Apr 13. Nat Cell Biol. 2008. PMID: 18408733

3

Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.

Nasr R, Guillemin MC, Ferhi O, Soilihi H, Peres L, Berthier C, Rousselot P, Robledo-Sarmiento M, Lallemand-Breitenbach V, Gourmel B, Vitoux D, Pandolfi PP, Rochette-Egly C, Zhu J, de Thé H. Nasr R, et al. Nat Med. 2008 Dec;14(12):1333-42. doi: 10.1038/nm.1891. Epub 2008 Nov 23. Nat Med. 2008. PMID: 19029980

4

Dimerization-induced corepressor binding and relaxed DNA-binding specificity are critical for PML/RARA-induced immortalization.

Zhou J, Pérès L, Honoré N, Nasr R, Zhu J, de Thé H. Zhou J, et al. Among authors: nasr r. Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9238-43. doi: 10.1073/pnas.0603324103. Epub 2006 Jun 6. Proc Natl Acad Sci U S A. 2006. PMID: 16757557 Free PMC article.

5

Acute promyelocytic leukemia: new issues on pathogenesis and treatment response.

Vitoux D, Nasr R, de The H. Vitoux D, et al. Among authors: nasr r. Int J Biochem Cell Biol. 2007;39(6):1063-70. doi: 10.1016/j.biocel.2007.01.028. Epub 2007 Mar 21. Int J Biochem Cell Biol. 2007. PMID: 17468032 Review.

6

Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure.

Nasr R, Lallemand-Breitenbach V, Zhu J, Guillemin MC, de Thé H. Nasr R, et al. Clin Cancer Res. 2009 Oct 15;15(20):6321-6. doi: 10.1158/1078-0432.CCR-09-0209. Epub 2009 Oct 6. Clin Cancer Res. 2009. PMID: 19808868 Review.

7

Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targeting.

Nasr R, de Thé H. Nasr R, et al. Int J Hematol. 2010 Jun;91(5):742-7. doi: 10.1007/s12185-010-0582-0. Epub 2010 May 11. Int J Hematol. 2010. PMID: 20455087

8

How animal models of leukaemias have already benefited patients.

Ablain J, Nasr R, Zhu J, Bazarbachi A, Lallemand-Breittenbach V, de Thé H. Ablain J, et al. Among authors: nasr r. Mol Oncol. 2013 Apr;7(2):224-31. doi: 10.1016/j.molonc.2013.01.006. Epub 2013 Feb 11. Mol Oncol. 2013. PMID: 23453906 Free PMC article. Review.

9

The drug-induced degradation of oncoproteins: an unexpected Achilles' heel of cancer cells?

Ablain J, Nasr R, Bazarbachi A, de Thé H. Ablain J, et al. Among authors: nasr r. Cancer Discov. 2011 Jul;1(2):117-27. doi: 10.1158/2159-8290.CD-11-0087. Cancer Discov. 2011. PMID: 22586354 Review.

10

Proapoptotic regimes for HTLV-I-transformed cells: targeting Tax and the NF-kappaB pathway.

Kfoury Y, Nasr R, Hermine O, de Thé H, Bazarbachi A. Kfoury Y, et al. Among authors: nasr r. Cell Death Differ. 2005 Aug;12 Suppl 1:871-7. doi: 10.1038/sj.cdd.4401624. Cell Death Differ. 2005. PMID: 15846376 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters